PRODUCTS
FlexISH ® NTRK1/NTRK3 DistinguISHTM Probe
The FlexISH ® NTRK1/NTRK3 DistinguISHTM Probe is designed to detect rearrangements affecting the chromosomal region 1q23.1 and 15q25.3 harboring the NTRK1 and NTRK3 gene region, respectively. The treatment of patients with NTRK fusion-positive cancers with a NTRK inhibitor is associated with high response rates, regardless of NTRK gene, fusion partner, and tumor type.
Probe Maps
Ordering Information
| Prod. No.: | Tests¹ (Volume): | Registration Status²: | ||
|---|---|---|---|---|
| Z-2314-50 |
|
 |
||
| Z-2314-200 |
|
|
Download Information
| 1 | Using 10 μl probe solution per test. |
| 2 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
